All the Active Ingredient Drugs
Nucleoside Reverse Transcriptase Inhibitor. Valganciclovir (as HCl) 450 mg. TABS.: 60.
Preven. of CMV dis. in pts. who have undergone a transplant: Start tmt. within 10 d. from the date of the transplant. Usual. dose: 2tabs.×1/d.. Cont. with this dosage for up to 100 d. follow. the transp. For kidney transp., the duration may cont. for 200 d. Tmt. of CMV retinitis in AIDS pts. Init. tmt. of an active infect. (induct. tmt.).: usual. dose 2 tabs. ×2/d for 21 days (3 wks). Long- term tmt. to prevent recur. of active inflame. in AIDS pts. with CMV retinitis (mainten. tmt.): Usual. dose: 2tabs.×1/d. same time each d. See lit.
Induct. & maintenan. tmt. of CMV retinitis in pts. with AIDS. For the prevent. of CMV dis. in CMV-negat. pts. who have received a solid organ transplant from a CMV-posit. donor.
C/I: Hypersens. Hypersens. to ganciclovir, aciclovir or to valaciclovir. Lact.
